Mitochondrial fitness influences neuronal excitability of dopaminergic neurons from patients with idiopathic form of Parkinson's disease
Paula ChlebanowskaiD, Agata SzlagaiD, Anna TejchmaniD, Marta KotiD, Paweł S. KoniecznyiD, Klaudia SkrzypekiD, Agata MuszyńskaiD, Małgorzata Katarzyna SobocińskaiD, Krystyna Golebiowska, Paweł P. ŁabajiD, Anna BłasiakiD, Marcin MajkaiD
Abstract
Parkinson disease is the second most common neurodegenerative disease defined by presence of Lewy bodies and the loss of dopaminergic neurons in the substantia nigra pars compacta (SNc). There are three types of PD - familial, early-onset and idiopathic. Idiopathic PD (IPD) accounts for approximately 90% of all PD cases. Mitochondrial dysfunction accompanies the pathogenesis of Parkinsons disease. Loss of mitochondrial function increases oxidative stress and calcium buffering, which in turn hinders the production of ATP and disrupts the functioning of dopaminergic neurons. The main barrier in PD research was the lack of proper human models to study the mechanisms of PD development and progression. Using induced pluripotent stem (iPS) cells we generated patient-specific dopaminergic neurons. We observed differences in the mitochondria fitness but not differences in mitochondria mass, morphology or membrane potential. Expression of OXPHOS mitochondrial complexes were lower in PD patients in comparison to control group what resulted in changes in mitochondria respiratory status. We observed also lower expression levels of Na+/K+-ATPase subunits and ATP-sensitive K+ (K-ATP) channel subunits. The lower oxygen consumption rate and extracellular acidification rate values were observed in dopaminergic progenitors and iPSC from PD patients compared to the control group. Importantly, observed decrease in the availability of ATP and in the energy consumption, as well as changes in acidification, may constitute contributing factors to the observed reduced neuronal excitability of PD patients dopaminergic neurons.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bioenergetic and Protein Processing Imbalances Synergize in iPSC-Dopamine neurons from Individuals with Idiopathic Parkinsons Disease
Kelsey Bernard, Mandi J. Corenblum, … Lalitha Madhavan·Neurobiology of DiseasePeer-reviewed·Dec 12, 2025
- Dopamine-iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease
Chiara Buoso, Markus Seifert, … Günter Weiß·Neurobiology of DiseasePeer-reviewed·Apr 21, 2024
- Parkinson's disease-related Miro1 mutation induces mitochondrial dysfunction and loss of dopaminergic neurons in vitro and in vivo
Axel Chemla, Giuseppe Arena, … Cláudia Saraiva·BrainPeer-reviewed·Feb 5, 2025
- Orthogonal analysis of mitochondrial function in Parkinson's disease patients
Sander Barnhoorn, Chiara Milanese, … Pier G. Mastroberardino·Cell Death and DiseasePeer-reviewed·Apr 3, 2024
- Mitochondrial DNA damage in substantia nigra parscompacta astrocytes exacerbates dopaminergic neuron lossin a 6-hydroxydopamine mouse model of parkinsonism
Daniela A. Ayala, Grace M Hall, … Rahul Srinivasan·Cellular and Molecular NeurobiologyPeer-reviewed·Mar 19, 2026
- Rare variants alter mitochondrial lipid homeostasis and neuronal excitability in PD patient-derived dopaminergic neurons
Federica Carrillo, Giorgio Fortunato, … Teresa Esposito·bioRxiv·Apr 10, 2026